Overall market sentiment has been down on Catabasis Pharmaceuticals Inc (CATB) stock lately. CATB receives a Bearish rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends.
Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.
InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.
The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.
What's Happening With CATB Stock Today?
Catabasis Pharmaceuticals Inc (CATB) stock is down -6.96% while the S&P 500 is higher by 0.17% as of 1:58 PM on Friday, Apr 16. CATB is lower by -$0.16 from the previous closing price of $2.37 on volume of 584,833 shares. Over the past year the S&P 500 has gained 50.09% while CATB is lower by -57.34%. CATB lost -$2.03 per share in the over the last 12 months.
To screen for more stocks like Catabasis Pharmaceuticals Inc click here.
More About Catabasis Pharmaceuticals Inc
Catabasis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company focuses on the discovery, development and commercialization of novel therapeutics.It develops products for the treatment of hereditary angioedema, or HAE, a rare, debilitating and potentially life-threatening disease. Its product candidate includes QLS-215.
Click Here to get the full Stock Score Report on Catabasis Pharmaceuticals Inc (CATB) Stock.
